Hennion & Walsh Asset Management, Inc. Aurinia Pharmaceuticals Inc. Transaction History

Hennion & Walsh Asset Management, Inc.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 17, 2024	BUY	$4.93 - $9.31 $24,861 - $46,950	5,043 Added 7.13%	75,787 $379,000
Q4 2023 Jan 10, 2024	BUY	$7.13 - $9.49 $61,731 - $82,164	8,658 Added 13.95%	70,744 $635,000
Q3 2023 Oct 27, 2023	BUY	$7.77 - $12.27 $19,153 - $30,245	2,465 Added 4.13%	62,086 $482,000
Q2 2023 Aug 09, 2023	SELL	$8.96 - $11.69 $894,996 - $1.17 Million	-99,888 Reduced 62.62%	59,621 $577,000
Q1 2023 Apr 20, 2023	SELL	$5.94 - $11.27 $31,493 - $59,753	-5,302 Reduced 3.22%	159,509 $1.75 Million
Q4 2022 Jan 12, 2023	SELL	$4.11 - $8.14 $562,552 - $1.11 Million	-136,874 Reduced 45.37%	164,811 $712,000
Q3 2022 Nov 14, 2022	BUY	$6.66 - $12.39 $24,222 - $45,062	3,637 Added 1.22%	301,685 $2.27 Million
Q2 2022 Jul 19, 2022	BUY	$8.95 - $12.8 $290,427 - $415,360	32,450 Added 12.22%	298,048 $3 Million
Q1 2022 Apr 26, 2022	SELL	$10.05 - $22.48 $44,290 - $99,069	-4,407 Reduced 1.63%	265,598 $3.29 Million
Q4 2021 Feb 14, 2022	SELL	$17.78 - $33.08 $194,086 - $361,101	-10,916 Reduced 3.89%	270,005 $6.18 Million
Q3 2021 Nov 12, 2021	BUY	$10.93 - $23.55 $266,451 - $574,101	24,378 Added 9.5%	280,921 $6.22 Million
Q2 2021 Aug 13, 2021	BUY	$10.0 - $14.52 $829,830 - $1.2 Million	82,983 Added 47.81%	256,543 $3.33 Million
Q1 2021 May 17, 2021	BUY	$12.3 - $18.73 $2.13 Million - $3.25 Million	173,560 New	173,560 $2.25 Million

191

56.7M

499K

637K

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $1.01B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

Get notified when there are updates to the investment portfolio of Hennion & Walsh Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Hennion & Walsh Asset Management, Inc. with notifications on news.